source
- GSK to buy Nuvalent for $10.6B, gaining two lung-cancer drugs under FDA reviewGSK announced it will acquire Nuvalent, a biotech focused on lung cancer, in a transaction valued at about $10.6 billion. The deal gives GSK control of Nuvalent’s two experimental lung-cancer ther…
- FDA adds bemotrizinol, first new sunscreen ingredient in 20 yearsThe U.S. Food and Drug Administration has approved bemotrizinol as a new active ingredient for over‑the‑counter sunscreens, marking the first addition to the sunscreen monograph since the late 1990…